Medlab Clinical - Cash position supported by A$3.6m R&D grant
Medlab Clinical has released its unaudited cash flow report for Q123 and provided an update for the period. The company’s cash position was...
495 Views
Medlab Clinical - Observational trials to support development
Medlab Clinical has announced it has received ethics approval to conduct two new observational clinical trials in Australia for its lead...
740 Views
Medlab Clinical - FY23 a year of clinical development
As part of its transformation into a pureplay biotech, Medlab is preparing an IND submission for NanaBis and plans to begin clinical trials with...
744 Views
Medlab Clinical - FY22 cash flows within our expectations
Medlab Clinical has released its cash flow report for Q422 and the full FY22 period. Net cash outflow from operating activities in FY22 was A$9.0m,...
751 Views
Medlab Clinical - NanaBis – now with synthetic CBD and THC
Following the company’s transformation to a pureplay biotech, Medlab Clinical has focused on the development of key asset NanaBis, a 50:50 micellar...
761 Views